Patient Support with COAGADEX

If you or someone you know has been recently diagnosed with HFXD and/or prescribed COAGADEX, resources are available!

Kedrion Connects

Patient and Caregiver Education & Training

Our Nurse Educators provide training and educational resources to help you:

  • Learn COAGADEX proper reconstitution, administration, and safe handling
  • Better understand hereditary factor X deficiency and its treatment
  • Connect with resources, such as patient groups and advocacy organizations

New Patient Support

We can help you navigate your treatment journey by providing assistance with:

  • Insurance benefit and drug coverage verification
  • Prior authorization
  • Financial assistance for eligible copays
  • Have your doctor or pharmacy complete the Kedrion Connects Enrollment Form to get started

Download the Kedrion Connects Enrollment Form Today

To enroll in Kedrion Connects, your healthcare provider must complete the New Start Form and Consent Form.

Have your doctor return completed forms to MedMonk:
Phone:888-262-8040
Fax:408-419-1768

Copay Support

If you have a valid prescription for COAGADEX, and are having trouble paying for your medication, we may be able to help!

The COAGADEX Copay Support Program:

  • Can help cover out-of-pocket expenses for a COAGADEX prescription. Some restrictions apply
  • Is easy to use, with no cards required

Have your doctor or pharmacy complete the Kedrion Connects Enrollment Form to start your enrollment

Speech bubbles icon
QUESTIONS? Call 888-262-8040. Kedrion Connects™ Support Services is available Monday to Friday, from 9 am to 7 pm ET (except holidays).

Hemophilia treatment centers

Many patients with bleeding disorders seek diagnosis and treatment at a Hemophilia Treatment Center (HTC). More than 140 HTCs are found across the US. They provide high-quality care for people with all types of bleeding disorders. Talk with your doctor about HTCs.

Specialty Pharmacies

Kedrion works with the following pharmacies to make COAGADEX available for you.

Accredo Health Group, Inc.

Optum Infusion Pharmacy

(including AHF, BioRx, and MedPro Rx)
specialty.optumrx.com/infusion
1-866-442-4679

Paragon Specialty

paragonhealthcare.com
1-888-588-1072

Connect with Us

As the maker of COAGADEX, Kedrion is here to support you.

Complete the form below to connect with us for more information or to ask a question.

You can also call toll-free: (844) 424-1010 (Monday through Friday, 9 am to 7 pm Eastern Time)

First name is required.
Last name is required.
Email is required.
Phone number is required.
City is required.
State is required.
Zip code is required.
I am a…*
Please select an option.
Please enter some information.
I am…*
Please select one or more options.
Please enter some information.
This checkbox is required.
This checkbox is required.
Note: The patient support program informs patients that medical advice can only be provided by their health care team. Patients are instructed to contact their doctor or another member of their health care team for any questions or concerns about their health and/or treatment.
*Required information
Replace exactly what's missing

Indications and Usage for COAGADEX

COAGADEX, a plasma-derived blood coagulation factor X concentrate, is indicated in adults and children with hereditary factor X deficiency for:

  • Routine prophylaxis to reduce the frequency of bleeding episodes
  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding in patients with mild, moderate and severe hereditary factor X deficiency

Contraindication for COAGADEX

COAGADEX is contraindicated in patients who have had life-threatening hypersensitivity reactions to COAGADEX.

Important Safety Information for COAGADEX

Allergic type hypersensitivity reactions, including anaphylaxis, are possible with COAGADEX. If symptoms occur, patients should discontinue use of the product immediately, contact their physician, and administer appropriate treatment.

The formation of neutralizing antibodies (inhibitors) to factor X is a possible complication in the management of individuals with factor X deficiency. Carefully monitor patients taking COAGADEX for the development of inhibitors by appropriate clinical observations and laboratory tests.

COAGADEX is made from human plasma and may contain infectious agents, e.g. viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent. No cases of transmission of viral diseases, vCJD or CJD, have been associated with the use of COAGADEX.

In clinical studies, the most common adverse reactions (frequency ≥5% of subjects) with COAGADEX were infusion site erythema, infusion site pain, fatigue and back pain.

Please see complete Prescribing Information for COAGADEX.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit https://www.fda.gov/medwatch, or call 1-800-FDA-1088.
You may also call Kedrion at 1-866-398-0825 or email US_Medicalinfo@kedrion.com.